by Ethan Perlstein | Sep 21, 2017 | Niemann-Pick Type A |
By Taryn Sumabat This summer at Perlara, we ramped up our efforts to develop a Drosophila model of Niemann-Pick Type A (NPA). NPA is a rare lysosomal storage disease caused by mutations in the gene Smpd1, which encodes an enzyme called acid sphingomyelinase (ASM)....
by Feba Sam | Feb 1, 2017 | Perlara science |
I, along with Nina, performed our first high-throughput screen – well really medium-throughput but high-throughput for us – on Niemann-Pick Type C (NPC) patient-derived fibroblasts a couple of months back. We wanted to do a pilot screen with the Microsource bioactives...
by Nina DiPrimio | Jan 12, 2017 | Perlara science |
Well it has been a little while since I wrote a post, and a lot has happened since then, which I am sure you read about in our blogs and tweets. We changed our company name, partnered with Novartis and started partnering with patient groups to engineer our organisms...
by Sangeetha Iyer | Jan 20, 2016 | Uncategorized |
Or in other words, bypass pathways. Happy 2016 everyone! Here at PLab things have gotten off to a great start. You’ll keep hearing updates from other members of our team right here! In the meantime, I figured we’d kick off the new year with a broad...
by Ethan Perlstein | Feb 28, 2015 | Blogposts |
On behalf of the PLab team, I would like to wish everyone a happy Rare Disease Day 2015! I hope you all will take a few minutes today to appreciate that 1 in 12 people on Earth is affected by a rare disease. In the spirit of raising awareness about rare diseases,...
